Education
About Us
Working with TipRanks
Follow Us
HeraMED Ltd. (DE:1I4)
FRANKFURT:1I4
Total Valuation
HeraMED Ltd. has a market cap or net worth of €28.75M. The enterprise value is €22.76M.
Market Cap€28.75M
Enterprise Value€22.76M
Share Statistics
HeraMED Ltd. has 1,116,287,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,116,287,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
HeraMED Ltd.’s return on equity (ROE) is -2.96 and return on invested capital (ROIC) is -370.62%.
Return on Equity (ROE)-2.96
Return on Assets (ROA)-2.77
Return on Invested Capital (ROIC)-370.62%
Return on Capital Employed (ROCE)-3.95
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.20
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of HeraMED Ltd. is ―. HeraMED Ltd.’s PEG ratio is 0.16.
PE Ratio―
PS Ratio131.32
PB Ratio27.61
Price to Fair Value27.61
Price to FCF-10.53
Price to Operating Cash Flow-12.74
PEG Ratio0.16
Income Statement
In the last 12 months, HeraMED Ltd. had revenue of 195.77K and earned ― in profits. Earnings per share was >-0.01.
Revenue195.77K
Gross Profit99.78K
Operating Income-2.66M
Pretax Income―
Net Income―
EBITDA-2.56M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.42M and capital expenditures 0.00, giving a free cash flow of -2.42M billion.
Operating Cash Flow-2.42M
Free Cash Flow-2.42M
Free Cash Flow per Share>-0.01
Dividends & Yields
HeraMED Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.41
52-Week Price Change130.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)43.78
Average Volume (3m)152.85K
Important Dates
HeraMED Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
HeraMED Ltd. as a current ratio of 3.00, with Debt / Equity ratio of 30.33%
Current Ratio3.00
Quick Ratio3.00
Debt to Market Cap0.01
Net Debt to EBITDA0.25
Interest Coverage Ratio-946.83
Taxes
In the past 12 months, HeraMED Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
HeraMED Ltd. EV to EBITDA ratio is -9.79, with an EV/FCF ratio of -10.27.
EV to Sales128.09
EV to EBITDA-9.79
EV to Free Cash Flow-10.27
EV to Operating Cash Flow-10.27
Balance Sheet
HeraMED Ltd. has €914.65K in cash and marketable securities with €282.39K in debt, giving a net cash position of €632.27K billion.
Cash & Marketable Securities€914.65K
Total Debt€282.39K
Net Cash€632.27K
Net Cash Per Share<€0.01
Tangible Book Value Per Share<€0.01
Margins
Gross margin is 71.57%, with operating margin of -1358.06%, and net profit margin of -1408.29%.
Gross Margin71.57%
Operating Margin-1358.06%
Pretax Margin-1408.29%
Net Profit Margin-1408.29%
EBITDA Margin-1309.03%
EBIT Margin-1358.06%
Analyst Forecast
The average price target for HeraMED Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―